14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $141.16 $183.01 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Jun 26, 2019 $3.79 $3.89 $3.70 $3.73 33 434
Jun 25, 2019 $3.80 $3.87 $3.64 $3.75 44 288
Jun 24, 2019 $3.88 $3.89 $3.77 $3.80 25 369
Jun 21, 2019 $3.82 $4.00 $3.76 $3.80 40 681
Jun 20, 2019 $3.94 $4.08 $3.76 $3.78 42 333
Jun 19, 2019 $4.04 $4.05 $3.88 $3.88 69 169
Jun 18, 2019 $4.01 $4.16 $3.94 $4.04 94 671
Jun 17, 2019 $3.96 $4.10 $3.92 $3.99 36 314
Jun 14, 2019 $3.83 $3.90 $3.82 $3.88 14 580
Jun 13, 2019 $3.75 $3.89 $3.75 $3.82 36 824
Jun 12, 2019 $3.66 $3.89 $3.62 $3.81 45 573
Jun 11, 2019 $3.84 $3.90 $3.70 $3.70 33 449
Jun 10, 2019 $3.64 $3.85 $3.63 $3.81 20 527
Jun 07, 2019 $3.62 $3.77 $3.59 $3.63 12 626
Jun 06, 2019 $3.68 $3.70 $3.56 $3.60 23 627
Jun 05, 2019 $3.65 $3.86 $3.65 $3.68 41 185
Jun 04, 2019 $3.88 $3.88 $3.56 $3.68 81 508
Jun 03, 2019 $3.73 $3.88 $3.66 $3.88 35 034
May 31, 2019 $3.73 $3.80 $3.65 $3.65 25 069
May 30, 2019 $3.84 $3.87 $3.65 $3.70 27 895
May 29, 2019 $3.67 $3.73 $3.61 $3.66 108 010
May 28, 2019 $3.96 $3.96 $3.63 $3.69 117 490
May 24, 2019 $3.76 $4.09 $3.75 $3.80 55 391
May 23, 2019 $3.72 $3.72 $3.60 $3.69 25 770
May 22, 2019 $3.87 $3.93 $3.70 $3.72 39 504
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT